use of biopolymer for the treatment of lesions of the digestive tract

摘要

PCT No. PCT/FR95/00399 Sec. 371 Date Dec. 30, 1996 Sec. 102(e) Date Dec. 30, 1996 PCT Filed Mar. 29, 1995 PCT Pub. No. WO95/26737 PCT Pub. Date Oct. 12, 1995Use of at least one polymer or one biopolymer, called HBGFPPs, specifically protecting the growth factors of families of FGFs and beta TGFs from tryptic degradation and not significantly inhibiting coagulation, in the manufacture of a drug for the treatment of lesions of the digestive tract and of primary or secondary derived tissues of the endoderm and the mesoderm.